Back to Results
First PageMeta Content
Alexion Pharmaceuticals / Eculizumab / Drug discovery / Paroxysmal nocturnal hemoglobinuria / Clinical trial / Glycogen storage disease type II / Health / Medicine / Rare diseases


Alexion to Acquire Synageva to Strengthen Global Leadership in Developing and Commercializing Transformative Therapies for Patients with Devastating and Rare Diseases -- Expands  Alexion’s  metabolic  franchise  wi
Add to Reading List

Document Date: 2015-05-06 06:45:36


Open Document

File Size: 444,87 KB

Share Result on Facebook
UPDATE